TrialAssure and Cancer Research UK Partner on AI Regulatory Authoring
LONDON, June 18, 2026 TrialAssure and Cancer Research UK’s Centre for Drug Development (CDD) have announced a strategic collaboration...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
LONDON, June 18, 2026 TrialAssure and Cancer Research UK’s Centre for Drug Development (CDD) have announced a strategic collaboration...
LONDON, UNITED KINGDOM | January 27, 2026 — Evestia Clinical, a leading independent global specialist Contract Research Organization (CRO),...
